Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma have?
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma has 92 citations in the OpenAlex counts ScholarIQ stores.
When was Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma published?
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma has 2009 year in the ScholarIQ index.
What is the open-access status of Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma?
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma has bronze oa status in the ScholarIQ index.
What is the DOI of Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma?
The DOI for Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma is on the source record.
What is the PMID of Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma?
The PMID for Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma is on the source record.
What is the OpenAlex record for Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma?
The OpenAlex for Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma is on the source record.